Use of β-blocker therapy in older patients after acute myocardial infarction in Ontario

CMAJ. Canadian Medical Association Journal

Volumn 161, Issue 11, 1999, Pages 1403-1408

  Rochon, Paula A ^a,b,c,d   Anderson, Geoffrey M ^b,c   Tu, Jack V ^b,c,d   Clark, Jocalyn P ^a   Gurwitz, Jerry H ^e,f   Szalai, John Paul ^c,g   Lau, Paula ^b  

^a Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LABETALOL; METOPROLOL; NADOLOL; PINDOLOL; PROPRANOLOL; SOTALOL; TIMOLOL;

ACUTE HEART INFARCTION; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CANADA; COMORBIDITY; DRUG CONTRAINDICATION; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION;

EID: 0033619748     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 1. Fallen EL, Cairns J, Dafoe W, Frasure-Smith N, Genest J, Massel D, et al. Management of the postmyocardial infarction patient: a consensus report - revision of 1991 CCS guidelines. Can J Cardiol 1995;11:477-86.
2. 2. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction): J Am Coll Cardiol 1996;28:1328-428.
3. 3. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-21.
4. 4. Aronow WS. Prevalence of use of β-blockers and of calcium channel blockers in older patients with prior myocardial infarction at the time of admission to a nursing home. J Am Geriatr Soc 1996;44:1075-7.
5. 5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279: 1200-5.
6. 6. Wilcox RG, Roland JM, Banks DC, Hampton JR, Mitchell JRA. Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. BMJ 1980;280:885-8.
7. 7. Hjalmarson A, Herlitz, Holmberg S, Ryden L, Swedberg K. The Goteborg metoprolol trial: effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67(Suppl 1):1-26-1-32.
8. 8. Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981;304:801-7.
9. 9. β-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. JAMA 1982;247:1707-14.
10. 10. Wenger NK, Speroff L, Packard B, Cardiovascular health and disease in women. N Engl J Med 1993;329:247-56.
11. 11. Wenger NK. Exclusion of the elderly and women from coronary trials: Is their quality of care compromised? JAMA 1992;268:1460-1.
12. 12. Sherman SS. Gender, health, and responsible research. In: Kaiser FE, editor. Clinics in geriatric medicine: care of the older woman. vol 9. Philadelphia: WB Saunders Company; 1993. p.261-9.
13. 13. Commission on Professional and Hospital Activities. International classification of diseases, ninth revision, clinical modification. Ann Arbor (MI): The Commission; 1992.
14. 14. McClellan M, McNeil BJ, Newhouse JP. Dues more intensive treatment of acute myocardial infarction in the elderly reduce mortality? JAMA 1994;272: 859-66.
15. 15. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993;270:1832-6.
16. 16. Normand ST, Glickman ME, Sharma RGV, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients; results from the Cooperative Cardiovascular Project. JAMA 1996;275:1322-8.
17. 17. Udvarhelyi IS, Gatsonis C, Epstein AM, Pashos CL, Newhouse JP, McNeil BJ. Acute myocardial infarction in the Medicare population: process of care and clinical outcomes. JAMA 1992;268:2530-6.
18. 18. Rochon PA, Fortin PR, Dear KBG, Minaker KL, Chalmers TC. Reporting of age data in clinical trials of arthritis; deficiencies and solutions. Arch Intern Med 1993;153:243-8.
19. 19. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
20. 20. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-9.
21. 21. Physicians' desk reference. 51st ed. Montvale (M1); Medical Economics Company; 1997.
22. 22. Joint Formulary Committee 1997-98. British National Formulary. September 1997 ed. vol 34. London: British Medical Association and Pharmaceutical Press; 1997.
23. 23. Canadian Pharmacists Association Group. Gillis MC, editor. Compendium of pharmaceuticals and specialities. 33rd ed. vol I. Ottawa: Canadian Pharmacists Association; 1998.
24. 24. Rochon PA, Anderson GM, Tu JV, Gurwitz JH, Clark JP, Shear NH, et al. Age-and gender-related use of low-dose drug therapy: the need to manufacture low-dose therapy and evaluate the minimum effective dose. J Am Geriatr Soc 1999;47:954-9.
25. 25. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction. National Cooperative Cardiovascular Project. JAMA 1998;280:623-9.
26. 26. Gottlieb SS, McCarter RJ, Vogel RA. Effect of β-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-97.
27. 27. Wenger NK. Coronary heart disease: an older woman's major health risk. BMJ 1997;315:1085-90.